borjatriol
7,14,15-trihydroxy-13-epoxylabdane
Identification
| Name | borjatriol |
| IUPAC | (1R)-1-[(3R,4aS,5S,6aS,10aS,10bR)-5-hydroxy-3,4a,7,7,10a-pentamethyl-2,5,6,6a,8,9,10,10b-octahydro-1H-benzo[f]chromen-3-yl]ethane-1,2-diol |
| CAS Number | 52591-03-4 |
| FDA UNII | Search |
| Molecular Formula | C20 H36 O4 |
| Molecular Weight | 340.50372000 |
| Nikkaji Number | J9.953H |
Regulatory
Physical Properties
| Assay | 95.00 to 100.00 |
| Food Chemicals Codex Listed | No |
| Boiling Point | 472.00 to 473.00 °C. @ 760.00 mm Hg (est) |
| Flash Point | 463.00 °F. TCC ( 239.30 °C. ) (est) |
| logP (o/w) | 3.276 (est) |
| Soluble in | alcohol |
| Insoluble in | water |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | natural substances and extractives |
| Recommendation for borjatriol usage levels up to | not for fragrance use. |
| Recommendation for borjatriol flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
(1R)-1-[(3R,4aS,5S,6aS,10aS,10bR)-5-
hydroxy-3,4a,7,7,10a-pentamethyl-2,5,6,6a,8,9,10,10b-octahydro-1H-benzo[f]chromen-3-yl]ethane-1,2-diol
7,14,15-
trihydroxy-13-epoxylabdane
PubMed:
Effect of borjatriol on nystatin oedema.
PubMed:
An approach to the antiinflammatory activity of borjatriol.
PubMed:
An approach to the antiinflammatory activity of borjatriol.
PubMed:
Effect of borjatriol on established adjuvant arthritis.